Clinical Trial Update: Phase II/III Randomized, Placebo-controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral Sclerosis [Phase 2, Phase 3]

View source ↗

Summary

A Phase II/III randomized, placebo-controlled trial evaluating arimoclomol in SOD1-positive familial amyotrophic lateral sclerosis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Arimoclomol (arimoclomol)

Snippet

Sponsor: University of Miami | Conditions: Amyotrophic Lateral Sclerosis | Phase 2, Phase 3 | Status: COMPLETED